Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
Pharming Group (Nasdaq: PHAR) announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference in New York, scheduled for September 8-10, 2025. CEO Fabrice Chouraqui will deliver a presentation on Monday, September 8 at 1:30pm EDT/19:30 CEST.
Investors can access the live webcast and replay through Pharming's website in the "Upcoming Events" and "News" sections. One-on-one meetings with management can be arranged through Investor Relations or H.C. Wainwright representatives.
Pharming Group (Nasdaq: PHAR) ha annunciato la sua partecipazione al 27¡ã H.C. Wainwright Annual Global Investment Conference che si terr¨¤ a New York dall'8 al 10 settembre 2025. Il CEO Fabrice Chouraqui terr¨¤ una presentazione luned¨¬ 8 settembre alle 13:30 EDT/19:30 CEST.
Gli investitori possono seguire la diretta e la registrazione sul sito di Pharming, nelle sezioni "Upcoming Events" e "News". Incontri individuali con il management possono essere organizzati tramite Investor Relations o i rappresentanti di H.C. Wainwright.
Pharming Group (Nasdaq: PHAR) anunci¨® su participaci¨®n en la 27? Conferencia Anual Global de Inversi¨®n de H.C. Wainwright en Nueva York, programada del 8 al 10 de septiembre de 2025. El CEO Fabrice Chouraqui ofrecer¨¢ una presentaci¨®n el lunes 8 de septiembre a la 1:30 p.m. EDT/19:30 CEST.
Los inversores podr¨¢n acceder a la transmisi¨®n en vivo y a la reproducci¨®n desde la p¨¢gina web de Pharming, en las secciones "Upcoming Events" y "News". Las reuniones individuales con la direcci¨®n pueden concertarse a trav¨¦s de Investor Relations o de los representantes de H.C. Wainwright.
Pharming Group (Nasdaq: PHAR)? 2025? 9? 8??? 10??? ???? ??? H.C. Wainwright ?27? ?? ??? ?? ????? ????? ??????. CEO Fabrice Chouraqui? 9? 8? ??? ?? 1:30 EDT/19:30 CEST? ??? ?????.
????? Pharming ????? "Upcoming Events" ? "News" ???? ??? ????? ????? ??? ? ????. ????? ??? ??? Investor Relations ?? H.C. Wainwright ???? ??°²ÅÅ? ? ????.
Pharming Group (Nasdaq: PHAR) a annonc¨¦ sa participation ¨¤ la 27e conf¨¦rence annuelle mondiale d'investissement H.C. Wainwright ¨¤ New York, pr¨¦vue du 8 au 10 septembre 2025. Le PDG Fabrice Chouraqui donnera une pr¨¦sentation le lundi 8 septembre ¨¤ 13h30 EDT/19h30 CEST.
Les investisseurs peuvent acc¨¦der au webdiffusion en direct et au replay via le site de Pharming, dans les rubriques "Upcoming Events" et "News". Des rendez?vous individuels avec la direction peuvent ¨ºtre organis¨¦s via Investor Relations ou les repr¨¦sentants de H.C. Wainwright.
Pharming Group (Nasdaq: PHAR) hat seine Teilnahme an der 27. H.C. Wainwright Annual Global Investment Conference in New York angek¨¹ndigt, die vom 8. bis 10. September 2025 stattfindet. CEO Fabrice Chouraqui wird am Montag, den 8. September, um 13:30 Uhr EDT/19:30 Uhr CEST eine Pr?sentation halten.
Investoren k?nnen das Live-Webcast und die Aufzeichnung ¨¹ber die Pharming-Website in den Bereichen "Upcoming Events" und "News" abrufen. Einzelgespr?che mit dem Management k?nnen ¨¹ber Investor Relations oder die Vertreter von H.C. Wainwright vereinbart werden.
- None.
- None.
Leiden, the?Netherlands, September 3, 2025: Pharming Group N.V. (¡°Pharming¡±) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025.
Fabrice Chouraqui, Chief Executive Officer, will present on Monday, September 8 at 1:30pm EDT/19:30 CEST. A live webcast and replay of the presentation can be found in the ¡°Upcoming Events¡± and ¡°News¡± sections of Pharming¡¯s website.
For more information about the conference, or to schedule a one-to-one meeting with Pharming¡¯s management team, please contact Investor Relations at or your H.C. Wainwright representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit and find us on .
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
Saskia Mehring, Corporate Communications Manager
T: +31 6 28 32 60 41
E:
FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E:
US PR
Ethan Metelenis
T: +1 (917) 882-9038
E:
Attachment
FAQ
When is Pharming Group (PHAR) presenting at the H.C. Wainwright Conference 2025?
How can investors watch Pharming Group's H.C. Wainwright Conference presentation?
Who will be presenting for Pharming Group at the H.C. Wainwright Conference?
How can investors schedule meetings with Pharming Group management at the conference?
